首页> 外文期刊>Pediatric and Developmental Pathology >Therapy-Related Acute Myeloid Leukemia with 11q23 Abnormality Coexisting with Refractory Metastatic Ewing Sarcoma: Report of a Case and Review of the Literature
【24h】

Therapy-Related Acute Myeloid Leukemia with 11q23 Abnormality Coexisting with Refractory Metastatic Ewing Sarcoma: Report of a Case and Review of the Literature

机译:与治疗相关的急性髓性白血病伴11q23异常与难治性转移性尤文氏肉瘤并存:一例报告并文献复习

获取原文
获取原文并翻译 | 示例
           

摘要

Intensified chemotherapy is one of the strategies currently used in the treatment of children with metastatic Ewing sarcoma. However, the increasing dose intensity has not significantly improved the event-free survival. We report a patient who initially presented with localized Ewing sarcoma and later developed metastatic disease that required dose-intensified chemotherapy. The patient's Ewing sarcoma remained refractory to treatment despite continuous intensified chemotherapy and was complicated by a therapy-related acute myeloid leukemia with 11q23 abnormality. Examination of bone marrow at the last clinical follow up demonstrated both acute myeloid leukemia and residual metastatic Ewing sarcoma.
机译:强化化疗是目前用于治疗转移性尤因肉瘤的儿童的策略之一。但是,增加的剂量强度并未显着改善无事件生存期。我们报告了一名患者,最初出现局限性尤因肉瘤,后来发展成转移性疾病,需要加大剂量的化疗。尽管持续加强化疗,患者的尤因肉瘤仍然难以治疗,并伴有与治疗有关的急性骨髓性白血病,伴有11q23异常。在最后一次临床随访中对骨髓的检查表明,急性髓细胞性白血病和残留的转移性尤因肉瘤均可见。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号